“Noncognitive” symptoms of early Alzheimer disease
暂无分享,去创建一个
J. Morris | C. Roe | John C Morris | Catherine M Roe | Mary Clare Masters | M. Masters | J. Morris | J. Morris | J. Morris
[1] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[2] J. K. Djernes,et al. Prevalence and predictors of depression in populations of elderly: a review , 2006, Acta psychiatrica Scandinavica.
[3] A. Fagan,et al. CSF biomarkers of Alzheimer disease , 2013, Neurology.
[4] D. Coakley,et al. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease , 2002, International journal of geriatric psychiatry.
[5] Francesco Raudino,et al. Non-cognitive symptoms and related conditions in the Alzheimer’s disease: a literature review , 2013, Neurological Sciences.
[6] I. McKeith,et al. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population , 2009, British Journal of Psychiatry.
[7] K. Blennow,et al. The relationship between cerebrospinal fluid biomarkers and depression in elderly women. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[8] J. Morris,et al. The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers , 2006, Alzheimer disease and associated disorders.
[9] W. Kamphorst,et al. Relation between neuritic plaques and depressive state in Alzheimer's disease , 2010, Acta Neuropsychiatrica.
[10] L. Tan,et al. Behavioral and Psychological Symptoms in Alzheimer's Disease , 2014, BioMed research international.
[11] S. Hui,et al. The relationship between non‐cognitive symptoms and functional impairment in Alzheimer's disease , 2004, International journal of geriatric psychiatry.
[12] Michael A Rapp,et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.
[13] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[14] K. Blennow,et al. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. , 2012, The American journal of psychiatry.
[15] T. Kurosaki,et al. Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.
[16] D. Perl,et al. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[17] J. Cummings,et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.
[18] Nathaniel Mercaldo,et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.
[19] R. Penn,et al. Stiff‐man syndrome treated with intrathecal baclofen , 1993, Neurology.
[20] P. Deyn,et al. Neuropsychological and behavioural correlates of CSF biomarkers in dementia , 2006, Neurochemistry International.
[21] D. Mograbi,et al. Anosognosia, autobiographical memory and self knowledge in Alzheimer's disease , 2013, Cortex.
[22] J. Yesavage,et al. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .